Home/Browse by collection/Adverse effects and drug safety

Adverse effects and drug safety

Showing results 41 - 50 of 78

Sorted by most recent

TitleAuthorDate

DOACs not recommended for people with antiphospholipid syndrome

27 November 2019

Renewed safety warnings for yellow fever vaccine

25 September 2019

MHRA drug safety update: risk of Fournier’s gangrene with SGLT2 inhibitors for diabetes

25 July 2019

New restrictions and precautions for the use of fluoroquinolones

25 July 2019

MHRA drug safety update: severe and fatal burns risk with emollients

24 April 2019

MHRA drug safety update: hydrochlorothiazide and non-melanoma skin cancer

24 April 2019

Oral lidocaine for infant teething reclassified as Pharmacy only

1 February 2019

MHRA Drug Safety Update: denosumab (Xgeva) and rebound hypercalcaemia

20 November 2018

Ulipristal acetate (Esmya): restrictions on use

22 October 2018

Pathways to faster access to medicines

1 August 2018

Prev 1 2 3 456 7 8 Next